Genome & Company, Inc. is a South Korea-based biotechnology company specializing in the discovery and development of novel target therapeutic agents with first-in-class potential, including but not limited to novel cancer target antibodies as stand-alone therapy and antibody-drug conjugate (ADC) applications, and novel fibrosis target small molecule candidates.